• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液成分治疗:何种成分、何时使用以及使用多少。

Blood component therapy: Which, when and how much.

作者信息

Arya Rajesh Chand, Wander Gs, Gupta Pankaj

机构信息

Department of Cardiac Anesthesiology, Hero DMC Heart Institute, Ludhiana.

出版信息

J Anaesthesiol Clin Pharmacol. 2011 Apr;27(2):278-84. doi: 10.4103/0970-9185.81849.

DOI:10.4103/0970-9185.81849
PMID:21772701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3127320/
Abstract

Blood transfusion refers to the perioperative administration of blood and blood components. Adherence to proper indications for blood component therapy is essential because of its potential adverse effects and costs of transfusion. Over the years, the significance of blood components in treating certain diseases or conditions has been recognized. In this article, the most commonly used blood components along with the new developments in component therapy have been discussed. Recommendations by different academic and clinical trials and studies have been presented for quick reference. The individual coagulation factors are discussed in brief.

摘要

输血是指围手术期给予血液和血液成分。由于输血存在潜在的不良反应和成本,因此严格遵循血液成分治疗的适当指征至关重要。多年来,血液成分在治疗某些疾病或病症中的重要性已得到认可。本文讨论了最常用的血液成分以及成分治疗的新进展。还列出了不同学术机构、临床试验和研究的建议以供快速参考。并简要讨论了各个凝血因子。

相似文献

1
Blood component therapy: Which, when and how much.血液成分治疗:何种成分、何时使用以及使用多少。
J Anaesthesiol Clin Pharmacol. 2011 Apr;27(2):278-84. doi: 10.4103/0970-9185.81849.
2
Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.血液成分治疗实践指南:美国麻醉医师协会血液成分治疗特别工作组报告
Anesthesiology. 1996 Mar;84(3):732-47.
3
Management of Coagulopathy in Postpartum Hemorrhage.
Semin Thromb Hemost. 2016 Oct;42(7):724-731. doi: 10.1055/s-0036-1593417. Epub 2016 Oct 3.
4
Massive transfusion: an overview of the main characteristics and potential risks associated with substances used for correction of a coagulopathy.大量输血:用于纠正凝血病的物质的主要特征及潜在风险概述
Transfus Apher Sci. 2012 Oct;47(2):235-43. doi: 10.1016/j.transci.2012.06.001. Epub 2012 Jul 5.
5
Perioperative blood and blood component therapy.围手术期血液及血液成分治疗
Can J Anaesth. 1992 Dec;39(10):1105-15. doi: 10.1007/BF03008382.
6
[Diagnosis and transfusion algorithm for the management of perioperative coagulopathy].[围手术期凝血病管理的诊断与输血算法]
Masui. 2008 Sep;57(9):1095-102.
7
Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.血液学中的关键问题:危重症患者的贫血、血小板减少症、凝血病及血液制品输注
Clin Chest Med. 2003 Dec;24(4):607-22. doi: 10.1016/s0272-5231(03)00100-x.
8
Perioperative haemotherapy: I. Indications for blood component transfusion.围手术期血液治疗:I. 血液成分输血的适应证
Can J Anaesth. 1992 Sep;39(7):695-707. doi: 10.1007/BF03008233.
9
Use of plasma in the management of central nervous system bleeding: evidence-based consensus recommendations.
Adv Ther. 2014 Jan;31(1):66-90. doi: 10.1007/s12325-013-0083-7. Epub 2013 Dec 14.
10
Perioperative interventions to decrease transfusion of allogeneic blood products.
Mayo Clin Proc. 1994 Jun;69(6):575-86. doi: 10.1016/s0025-6196(12)62250-2.

引用本文的文献

1
Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma.美国使用 COVID-19 恢复期血浆实际和潜在挽救的生命估计。
Proc Natl Acad Sci U S A. 2024 Oct 8;121(41):e2414957121. doi: 10.1073/pnas.2414957121. Epub 2024 Oct 1.
2
Cultural competences among future nurses and midwives: a case of attitudes toward Jehovah's witnesses' stance on blood transfusion.未来护士和助产士的文化能力:以对耶和华见证人在输血问题上立场的态度为例。
BMC Med Educ. 2024 Jun 15;24(1):663. doi: 10.1186/s12909-024-05646-1.
3
Maximum surgical blood ordering schedule for elective surgical procedures in Omdurman teaching hospital, Sudan.苏丹奥姆杜尔曼教学医院择期手术的最大手术备血量表。
BMC Surg. 2024 Jun 1;24(1):173. doi: 10.1186/s12893-024-02458-4.
4
Use of Cryoprecipitate in Newborn Infants.冷沉淀在新生儿中的应用。
Newborn (Clarksville). 2023 Jan-Mar;2(1):11-18. doi: 10.5005/jp-journals-11002-0045. Epub 2023 Apr 6.
5
An insight to the internal quality control of blood components separated using the latest whole blood collection and processing systems: Experience from a tertiary care hospital blood transfusion service in Eastern India.对使用最新全血采集和处理系统分离的血液成分内部质量控制的见解:来自印度东部一家三级护理医院输血服务的经验。
Asian J Transfus Sci. 2022 Jul-Dec;16(2):194-200. doi: 10.4103/ajts.ajts_52_21. Epub 2022 May 26.
6
Intestinal Transplantation in a Country Without Home Parenteral Nutrition: The Largest Report from the Middle East.在没有家庭肠外营养的国家进行肠移植:来自中东的最大报告。
Turk J Gastroenterol. 2022 Sep;33(9):793-802. doi: 10.5152/tjg.2022.21708.
7
The clinical demand and supply of blood in India: A National level estimation study.印度的血液临床需求与供应:一项国家级评估研究。
PLoS One. 2022 Apr 6;17(4):e0265951. doi: 10.1371/journal.pone.0265951. eCollection 2022.
8
Thrombocytopenia in malaria patients from an arid region of Western Rajasthan (India).印度拉贾斯坦邦西部干旱地区疟疾患者的血小板减少症。
Trop Parasitol. 2020 Jul-Dec;10(2):95-101. doi: 10.4103/tp.TP_68_19. Epub 2021 Jan 25.
9
Recent advances in use of fresh frozen plasma, cryoprecipitate, immunoglobulins, and clotting factors for transfusion support in patients with hematologic disease.血液疾病患者输血支持中新鲜冰冻血浆、冷沉淀、免疫球蛋白和凝血因子应用的最新进展。
Semin Hematol. 2020 Apr;57(2):73-82. doi: 10.1053/j.seminhematol.2020.07.006. Epub 2020 Jul 27.
10
Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.生物材料与先进技术在出血止血管理中的应用
Adv Mater. 2018 Jan;30(4). doi: 10.1002/adma.201700859. Epub 2017 Nov 22.

本文引用的文献

1
Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies.围手术期输血及辅助治疗实践指南:美国麻醉医师协会围手术期输血及辅助治疗特别工作组的最新报告
Anesthesiology. 2006 Jul;105(1):198-208. doi: 10.1097/00000542-200607000-00030.
2
Haemoglobin-based erythrocyte transfusion substitutes.基于血红蛋白的红细胞输血替代品。
Expert Opin Biol Ther. 2001 Sep;1(5):831-43. doi: 10.1517/14712598.1.5.831.
3
Lyophilized platelets: continued development.冻干血小板:持续研发。
Transfus Sci. 2000 Feb-Apr;22(1-2):99-105. doi: 10.1016/s0955-3886(00)00028-x.
4
Preclinical testing of lyophilized platelets as a product for transfusion medicine.
Transfus Sci. 1995 Jun;16(2):183-5. doi: 10.1016/0955-3886(95)97401-k.
5
A pilot study of the effects of a perflubron emulsion, AF 0104, on mixed venous oxygen tension in anesthetized surgical patients.
Anesth Analg. 1996 Jan;82(1):103-7. doi: 10.1097/00000539-199601000-00018.
6
Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets.
Transfusion. 1996 Jun;36(6):536-42. doi: 10.1046/j.1537-2995.1996.36696269513.x.
7
Collection and transfusion of blood and blood components in the United States, 1989.1989年美国血液及血液成分的采集与输血情况
Transfusion. 1993 Feb;33(2):139-44. doi: 10.1046/j.1537-2995.1993.33293158046.x.
8
Guidelines for blood utilization review.
Transfusion. 1994 May;34(5):438-48. doi: 10.1046/j.1537-2995.1994.34594249058.x.
9
The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery.一种术中治疗算法对心脏手术中医师输血实践的影响。
Transfusion. 1994 Apr;34(4):290-6. doi: 10.1046/j.1537-2995.1994.34494233575.x.
10
Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists.新鲜冰冻血浆、冷沉淀和血小板使用的实践参数。美国病理学家学会新鲜冰冻血浆、冷沉淀和血小板输注实践指南制定工作组
JAMA. 1994 Mar 9;271(10):777-81.